Release Date: 29/06/12 16:45 Summary: Boardroom Radio Interview with Tim Dobson Price Sensitive: No Download Document 256.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%